Supplementary Table S1 from Negative Hyperselection of Patients with HER2<sup>+</sup> and <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study
Randon G., Nakamura Y., Yaeger R., Lonardi S., Cremolini C., Elez E., Nichetti F., Ghelardi F., Nasca V., Bergamo F., Conca V., Ros J., Bando H., Maddalena G., Oldani S., Prisciandaro M., Raimondi A., Schrock AB., Agnelli L., Walch H., Yoshino T., Pietrantonio F.
<p>This table summarizes the different screening sources and the corresponding NGS assays.</p>